(S)-2-Amino-3-(4-hydroxyphenyl)propanoic acid hydrochloride, 95.0%, 1g

Pentafluorophenyl trimethylsilane, 95%, 10g

Ethyl 2-(3,5-difluoro-phenoxy)acetate, 97.0%, 1g

(R)-2-((TERT-BUTOXYCARBONYL)AMINO)-5-(DIMETHYLAMINO)-5-OXOPENTANOIC ACID, 95.0%, 100mg

(diazyn-1-ium-1-yl)(6-hydroxyhexyl)azanide, 95%, 250mg

HARPAGOSIDE, 97%, 5mg

Benzofuran-6-ol, 95.0%, 500mg

Ethyl 3,3-difluorobutanoate, 97.0%, 1g

(R,S)-tert-Butyl 3-methyl-4-oxopiperidine-1-carboxylate, 95.0%, 100g

(2R)-3-({2-amino-9-[(4-fluorophenyl)methyl]-6-oxo-6,9-dihydro-3H-purin-8-yl}sulfanyl)-2-acetamidopropanoic acid, 98%, 250mg

(R)-4-(3-Bromophenyl)-3-((tert-butoxycarbonyl)amino)butanoic acid, 95.0%, 5g

Ethylenediamine Monohydrate>98.0%(T)25mL

((5-Bromopyridin-3-yl)imino)dimethyl-l6-sulfanone, 98%, 100mg